Laney, Dawn A.
Gupta, Divya
Wechsler, Stephanie B.
Article History
First Online: 3 May 2018
Compliance with Ethical Standards
:
: Dawn A. Laney reports receiving grants, consulting, speaking, and serving on North American Fabry Registry Board with Sanofi-Genzyme, grants and speaking from Shire, cofounder of ThinkGenetic, Inc., and grants from Amicus Therapeutics, outside the submitted work. Divya Gupta reports grants from Otsuka Pharmaceuticals, Inc., outside the submitted work. Stephanie B. Wechsler declares no conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.